leadership
You are here
Executive Management
William G. Rice, Ph.D.
President and Chief Executive Officer
Daniel D. Von Hoff, M.D., F.A.C.P.
Co-founder and Senior VP, Medical Affairs
John K.C. Lim, Pharm.D.
Senior VP, Clinical and Regulatory Affairs
David M. Ryckman, Ph.D.
Senior VP, Chemistry and Pharmaceutical Operations
Sean E. O'Brien, Ph.D.
VP, Research and Business Development
Denis Drygin, Ph.D.
VP, Biology
Irene Alicea
Executive Director, Resource Management
Board of Directors
Dr. Erich Platzer, M.D.
Chairman of the Board, HBM Partners
Reinhard J. Ambros, Ph.D.
Executive Director and Head of the Novartis Venture Funds globally
Peter Feinstein
General Partner, BioVentures Investors
Fred A. Middleton
General Partner, Sanderling Ventures
S. Edward Torres
Managing Director, Lilly Ventures
Daniel D. Von Hoff, M.D., F.A.C.P.
Independent Director
William G. Rice, Ph.D.
President and Chief Executive Officer
Scientific Advisory Board
Daniel D. Von Hoff, M.D., F.A.C.P.
Chairman of Scientific Advisory Board
Brian Druker, M.D.
Professor, Oregon Health & Science University Cancer Center
Walter Gilbert, Ph.D.
Nobel Laureate and Managing Director, Bioventures Investors
Vincent A. Miller, M.D
Professor, Memorial Sloan Kettering Cancer Center
Stephen Howell, M.D.
Professor, Moores Cancer Center, University of California, San Diego
Jerome Birnbaum, Ph.D.
Principal, Peartree Pharma R&D Consulting
Ingrid Grummt, Ph.D.
Professor and Division Head, German Cancer Research Center
Nancy Maizels, Ph.D.
Professor, University of Washington
Ross Hanan, Ph.D.
Associate Professor and Program Head, Peter MacCallum Cancer Centre